(NASDAQ:CNAT) Archives - Market Exclusive

Home Tags (NASDAQ:CNAT)

CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - April 2, 2019

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) gets downgraded to Neutral by HC Wainwright

ME Staff - March 22, 2019

CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT) Files An 8-K Results of Operations and...

ME Staff 8-k - March 8, 2019

CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT) Files An 8-K Termination of a Material...

ME Staff 8-k - December 6, 2018

Analyst Activity – SunTrust Banks Lowers Its Price Target On CNAT...

ME Staff - April 5, 2018

Here’s What’s Moving Conatus And Paratek

ME Staff - April 5, 2018

Analyst Activity – HC Wainwright Reiterates Buy on Conatus Pharmaceuticals (NASDAQ:CNAT)

ME Staff - March 8, 2018

Analyst Activity – Roth Capital Initiates Coverage On Conatus Pharmaceuticals (NASDAQ:CNAT)...

ME Staff - February 8, 2018

CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT) Files An 8-K Departure of Directors or...

ME Staff 8-k - February 6, 2018

Analyst Activity – Stifel Nicolaus Reiterates Buy on Conatus Pharmaceuticals (NASDAQ:CNAT)

ME Staff - August 3, 2017

12 3 Page 1 of 3

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Market Morning: Alexa Spying, Boeing Sensor History, Macron Spoils Scallop Dinner

April 11, 2019

ICC, AgraFlora to Bring Native Colombian Cannabis Strains to 39K Retail...

April 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: (NASDAQ:CNAT)